Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center

Patricia G. Wheeler(Nemours Children's Clinic), Diana W. Bianchi(National Human Genome Research Institute), Rosemarie Smith(Maine Medical Center), Henry L. Dorkin(Boston Children's Hospital), Richard B. Parad(Brigham and Women's Hospital), Anne Marie Comeau(University of Massachusetts Chan Medical School)
Genetics in Medicine
November 1, 2001
10.1097/00125817-200111000-00006
Cited by 41

Related Papers

First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
|New England Journal of Medicine|2005|1.1k
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951
Impact of Maternal Age on Obstetric Outcome
|Obstetrics and Gynecology|2005|858
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|458